The Queen Elizabeth Hospital Birmingham is a major, 1,215 bed, tertiary NHS and military hospital in the Edgbaston area of Birmingham, situated very close to the University of Birmingham.

There are 1,215 beds in Queen Elizabeth Medical Centre.

During the past decade, Queen Elizabeth Medical Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Elizabeth Medical Centre" #1 sponsor was "Intercept Pharmaceuticals" with 2 trials, followed by "Ipsen" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "Human Genome Sciences Inc." with 1 trials sponsored and "Imperial College London" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth Medical Centre" #1 collaborator was "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 1 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator, "Myeloma UK" with 1 trials as a collaborator and "National Health and Medical Research Council, Australia" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Queen Elizabeth Medical Centre" are "Liver Cirrhosis, Biliary" (2 trials), "Acromegaly" (1 trials), "Chronic Hepatitis C" (1 trials), "Dyslipidemias" (1 trials) and "Kidney Transplantation" (1 trials). Many other conditions were trialed in "Queen Elizabeth Medical Centre" in a lesser frequency.

Most popular intervention types in "Queen Elizabeth Medical Centre" are "Drug" (7 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "3-dimensional conformal radiation therapy" (1 trials), "Alirocumab" (1 trials), "Atorvastatin 80mg" (1 trials) and "Continuous infusion" (1 trials). Other intervention names were less common.

The vast majority of trials in "Queen Elizabeth Medical Centre" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Queen Elizabeth Medical Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Queen Elizabeth Medical Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Queen Elizabeth Medical Centre, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".